dr. lori pierce on the impact of brca1/2 mutations on breast cancer treatment decisions
Published 11 years ago • 269 plays • Length 1:43Download video MP4
Download video MP3
Similar videos
-
1:12
impact of hormones on brca breast cancer risk
-
17:33
tackling health inequities in cancer care: an interview with asco president dr. lori pierce
-
41:30
oncologist explains lesser known causes, risk factors, and treatments for breast cancer
-
13:33
dr. lori pierce | san antonio breast cancer symposium 2022 | general session
-
1:27
dr. litton on the impact of parp inhibitors in breast cancer
-
9:21
dr. litton on activity of talazoparib in advanced brca1/2 breast cancer
-
4:24
the latest treatment options for brca-mutated breast cancer
-
1:52
parpi for somatic brca1/2 and other dna repair gene mutations in women with metastatic breast cancer
-
3:16
new diagnostic tool in battle against breast cancer l gma
-
28:31
virtual pink house: tamoxifen & aromatase inhibitors in er breast cancer
-
3:52
understanding brca mutations and risk
-
6:30
sabcs 2023: a look into new research for inflammatory breast cancer
-
1:54
how palbociclib helps christine live her life with secondary breast cancer
-
1:40:59
the latest research on breast cancer
-
0:49
dr. tung discusses the role of olaparib in breast cancer
-
1:15
dr. robson on the toxicity profile of olaparib in breast cancer
-
7:13
final insight: parps and gbrca in breast cancer
-
0:45
dr. hamilton on using pcr to classify risk in her2 breast cancer
-
4:00
inflammatory breast cancer: a new scoring system proposed
-
2:50
new research into ways to lower your cancer risk
-
2:05
dr. white describes the br-002 trial in breast cancer
-
23:52
breast cancer and the immune system at mbc patient forum 2019